Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Landi

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
Bioconjugate Chemistry|October 27, 2025
Development of a Mesothelin-Binding Engineered Scaffold Protein as a Theranostic for Pleural MesotheliomaRoberto Silvestri, Margherita Piccardi, Alessia Laurenza, et al.
Frontiers in Genetics|October 5, 2020
Variation rs2235503 C > A Within the Promoter of <i>MSLN</i> Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related PeptideRoberto Silvestri, Perla Pucci, Chiara De Santi, et al.
Surgical Innovation|April 13, 2026
Robot-Assisted Liver Resection With Versius<sup>®</sup> Surgical System: COMPAR-L Prospective StudyLaura Alaimo, Tommaso Campagnaro, Simone Conci, et al.
Mutation Research|March 17, 2015
Expression status of candidate genes in mesothelioma tissues and cell linesOmbretta Melaiu, Erika Melissari, Luciano Mutti, et al.
International Journal of Cancer|February 10, 2007
Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesotheliomaStefano Landi, Federica Gemignani, Monica Neri, et al.
Thyroid : Official Journal of the American Thyroid Association|December 14, 2020
Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 SystemAlda Corrado, Romina Aceto, Roberto Silvestri, et al.
Surgical Endoscopy|June 10, 2026
Da Vinci<sup>®</sup> X<sup>™</sup>, Versius<sup>®</sup>, and Hugo<sup>™</sup> RAS in minimally invasive robotic-assisted hysterectomy: the COMPAR-HYST prospective studySimone Garzon, Stefano Landi, Alessandra Da Ros, et al.
Journal of Clinical Gastroenterology|September 14, 2016
A Primary-Care Interventional Model on the Diverticular Disease: Searching for the Optimal Therapeutic ScheduleAngelo Campanini, Umberto De Conto, Francesco Cavasin, et al.
Frontiers in Genetics|June 27, 2024
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cellsRoberto Silvestri, Lorenzo Zallocco, Alda Corrado, et al.
Mutation Research|September 16, 2009
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolismFederica Gemignani, Monica Neri, Fabio Bottari, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Bioconjugate Chemistry|October 27, 2025
Development of a Mesothelin-Binding Engineered Scaffold Protein as a Theranostic for Pleural MesotheliomaRoberto Silvestri, Margherita Piccardi, Alessia Laurenza, et al.
Frontiers in Genetics|October 5, 2020
Variation rs2235503 C > A Within the Promoter of <i>MSLN</i> Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related PeptideRoberto Silvestri, Perla Pucci, Chiara De Santi, et al.
Surgical Innovation|April 13, 2026
Robot-Assisted Liver Resection With Versius<sup>®</sup> Surgical System: COMPAR-L Prospective StudyLaura Alaimo, Tommaso Campagnaro, Simone Conci, et al.
Mutation Research|March 17, 2015
Expression status of candidate genes in mesothelioma tissues and cell linesOmbretta Melaiu, Erika Melissari, Luciano Mutti, et al.
International Journal of Cancer|February 10, 2007
Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesotheliomaStefano Landi, Federica Gemignani, Monica Neri, et al.
Thyroid : Official Journal of the American Thyroid Association|December 14, 2020
Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 SystemAlda Corrado, Romina Aceto, Roberto Silvestri, et al.
Surgical Endoscopy|June 10, 2026
Da Vinci<sup>®</sup> X<sup>™</sup>, Versius<sup>®</sup>, and Hugo<sup>™</sup> RAS in minimally invasive robotic-assisted hysterectomy: the COMPAR-HYST prospective studySimone Garzon, Stefano Landi, Alessandra Da Ros, et al.
Journal of Clinical Gastroenterology|September 14, 2016
A Primary-Care Interventional Model on the Diverticular Disease: Searching for the Optimal Therapeutic ScheduleAngelo Campanini, Umberto De Conto, Francesco Cavasin, et al.
Frontiers in Genetics|June 27, 2024
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cellsRoberto Silvestri, Lorenzo Zallocco, Alda Corrado, et al.
Mutation Research|September 16, 2009
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolismFederica Gemignani, Monica Neri, Fabio Bottari, et al.
Pageof 22